Pulmonary oxidant stress in murine sepsis is due to inflammatory cell nitric oxide

Critical Care Medicine

Volumn 33, Issue 6, 2005, Pages 1333-1339

  Razavi, Habib M ^a,b   Wang, Lefeng ^a,b   Weicker, Sean ^a,b   Quinlan, Greg J ^c   Mumby, Sharon ^a,b,c   McCormack, David G ^a,b   Mehta, Sanjay ^a,b,c  

^a LAWSON HEALTH RESEARCH INSTITUTE   (Canada)

^b UNIVERSITY OF WESTERN ONTARIO   (Canada)

^c ROYAL BROMPTON HOSPITAL   (United Kingdom)

Author keywords

3 nitrotyrosine; 8 isoprostane; Acute lung injury; Neutrophil; Nitric oxide; Sepsis

Indexed keywords

3 NITROTYROSINE; INDUCIBLE NITRIC OXIDE SYNTHASE; ISOPROSTANE DERIVATIVE; MYELOPEROXIDASE;

ACUTE LUNG INJURY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; INFLAMMATORY CELL; LIGATION; MACROPHAGE; MALE; MOUSE; NEUTROPHIL; NITRATION; NONHUMAN; OXIDATIVE STRESS; PERFORATION; PRIORITY JOURNAL; SEPSIS; WILD TYPE;

ANALYSIS OF VARIANCE; ANIMALS; BONE MARROW TRANSPLANTATION; CHIMERA; DINOPROST; LUNG; MACROPHAGES, ALVEOLAR; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NEUTROPHILS; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE II; OXIDATIVE STRESS; RANDOM ALLOCATION; RESPIRATORY DISTRESS SYNDROME, ADULT; SEPSIS; TYROSINE;

EID: 20444474987     PISSN: 00903493     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.CCM.0000165445.48350.4F     Document Type: Article

References (74)

1. Pepe PE: The clinical entity of adult respiratory distress syndrome. Definition, prediction, and prognosis. Crit Care Clin 1986; 2:377-403
2. Kollef MH, Schuster DP: The acute respiratory distress syndrome. N Engl J Med 1995: 332:27-37
3. Kobayashi A, Hashimoto S, Kooguchi K, et al: Expression of inducible nitric oxide synthase and inflammatory cytokines in alveolar macrophages of ARDS following sepsis. Chest 1998; 113:1632-1639
4. Razavi HM, Werhun R, Scott JA, et al: Effects of inhaled nitric oxide in a mouse model of sepsis-induced acute lung injury. Crit Care Med 2002; 30:868-873
5. Scott JA, Mehta S, Duggan M, et al: Functional inhibition of constitutive nitric oxide synthase in a rat model of sepsis. Am J Respir Crit Care Med 2002; 165:1426-1432
6. Nathan CF, Hibbs JB Jr: Role of nitric oxide synthesis in macrophage antimicrobial activity. Curr Opin Immunol 1991; 3:65-70
7. MacMicking JD, Nathan C, Hom G, et al: Altered responses to bacterial infection and endotoxic shock in mice lacking inducible nitric oxide synthase. Cell 1995; 81:641-650
8. [published erratum appears in Cell 1995; 81: following 1170]
9. McQuaid KE, Keenan AK: Endothelial barrier dysfunction and oxidative stress: Roles for nitric oxide? Exp Physiol 1997; 82:369-376
10. Wang LF, Patel M, Razavi HM, et al: Role of inducible nitric oxide synthase in pulmonary microvascular protein leak in murine sepsis. Am J Respir Crit Care Med 2002; 165: 1634-1639
11. Razavi HM, Wang LF, Weicker S, et al: Pulmonary neutrophil infiltration in murine sepsis: Role of inducible nitric oxide synthase. Am J Respir Crit Care Med 2004; 170: 227-233
12. Kristof AS, Goldberg P, Laubach V, et al: Role of inducible nitric oxide synthase in endotoxin-induced acute lung injury. Am J Respir Crit Care Med 1998; 158:1883-1889
13. Cobb JP, Hotchkiss RS, Swanson PE, et al: Inducible nitric oxide synthase (iNOS) gene deficiency increases the mortality of sepsis in mice. Surgery 1999; 126:438-442
14. Hollenberg SM, Broussard M, Osman J, et al: Increased microvascular reactivity and improved mortality in septic mice lacking inducible nitric oxide synthase. Circ Res 2000; 86:774-778
15. Titheradge MA: Nitric oxide in septic shock. Biochim Biophys Acta 1999; 1411:437-455
16. Wang LF, Mehta S, Weicker S, et al: Relative contribution of hemopoietic and pulmonary parenchymal cells to lung inducible nitric oxide synthase (iNOS) activity in murine endotoxemia. Biochem Biophys Res Commun 2001; 283:694-699
17. Hickey MJ, Sihota E, Amrani A, et al: Inducible nitric oxide synthase (iNOS) in endotoxemia: Chimeric mice reveal different cellular sources in various tissues. FASEB J 2002; 16:1141-1143
18. Robbins RA, Springall DR, Warren JB, et al: Inducible nitric oxide synthase is increased in murine lung epithelial cells by cytokine stimulation. Biochem Biophys Res Commun 1994; 198:835-843
19. Fujii Y, Goldberg P, Hussain SNA: Contribution of macrophages to pulmonary nitric oxide production in septic shock. Am J Respir Crit Care Med 1998; 157:1645-1651
20. Kwon YM, Shinozuka K, Kagota S, et al: Both extracellular ATP and shear stress regulate the release of nitric oxide in rat caudal artery. Clin Exp Pharm Phys 1999; 26:465-469
21. Yap GS, Sher A: Effector cells of both non-hemopoietic and hemopoietic origin are required for interferon (IFN)-γ- and tumor necrosis factor (TNF)-α-dependent host resistance to the intracellular pathogen, Toxoplasma gondii. J Exp Med 1999; 189: 1083-1091
22. Ignarro LJ: Signal transduction mechanisms involving nitric oxide. Biochem Pharm 1991; 41:485-490
23. Abu-Soud HM, Hazen SL: Nitric oxide modulates the catalytic activity of myeloperoxidase. J Biol Chem 2000; 275:5425-5430
24. Mohr S, Hallak H, de Boitte A, et al: Nitric oxide induced S-glutathionylation and inactivation of glyceraldehyde-3-phosphate dehydrogenase. J Biol Chem 1999; 274: 9427-9430
25. Williams DL: Nitrosating agents: Is peroxynitrite a likely candidate? Nitric Oxide 1997; 1:522-527
26. Rubbo H, Radi R, Trujillo M, et al: Nitric oxide regulation of superoxide and peroxynitrite-dependent lipid peroxidation. Formation of novel nitrogen-containing oxidized lipid derivatives. J Biol Chem 1994; 269: 26066-26075
27. Radi R, Beckman JS, Bush KM, et al: Peroxynitrite oxidation of sulfhydryls. The cytotoxic potential of superoxide and nitric oxide. J Biol Chem 1991; 266:4244-4250
28. Radi R, Beckman JS, Bush KM, et al: Peroxynitrite-induced membrane lipid peroxidation: The cytotoxic potential of superoxide and nitric oxide. Arch Biochem Biophys 1991; 288:481-487
29. Beckman JS, Beckman TW, Chen J, et al: Apparent hydroxyl radical production by peroxynitrite: Implications for endothelial injury from nitric oxide and superoxide. Proc Natl Acad Sci U S A 1990; 87:1620-1624
30. Ducrocq C, Blanchard B, Pignatelli B, et al: Peroxynitrite: An endogenous oxidizing and nitrating agent. Cell Mol Life Sci 1999; 55: 1068-1077
31. Javeshghani D, Magder S: Presence of nitrotyrosine with minimal inducible nitric oxide synthase induction in lipopolysaccharide-treated pigs. Shock 2001; 16:304-311
32. Bian K, Murad F: Diversity of endotoxin-induced nitrotyrosine formation in macrophage-endothelium-rich organs. Free Radic Biol Med 2001; 31:421-429
33. Haddad IY, Beckman JS, Carver RI, et al: Structural and functional alterations of surfactant protein A by peroxynitrite. Chest 1994; 105:848.
34. Lamb NJ, Quinlan GJ, Westerman ST, et al: Nitration of proteins in bronchoalveolar lavage fluid from patients with acute respiratory distress syndrome receiving inhaled nitric oxide. Am J Respir Crit Care Med 1999; 160:1031-1034
35. Webert KE, Vanderzwan J, Duggan M, et al: Effects of inhaled nitric oxide in a rat model of Pseudomonas aeruginosa pneumonia. Crit Care Med 2000; 28:2397-2405
36. van der Vliet A, O'Neill CA, Halliwell B, et al: Aromatic hydroxylation and nitration of phenylalanine and tyrosine by peroxynitrite. Evidence for hydroxyl radical production from peroxynitrite. FEBS Lett 1994; 339:89-92
37. Heremans H, Dillen C, Groenen M, et al: Role of interferon-γ and nitric oxide in pulmonary edema and death induced by lipopolysaccharide. Am J Respir Crit Care Med 2000; 161: 110-117
38. Mikawa K, Nishina K, Tamada M, et al: Aminoguanidine attenuates endotoxin-induced acute lung injury in rabbits. Crit Care Med 1998; 26:905-911
39. Numata M, Suzuki S, Miyazawa N, et al: Inhibition of inducible nitric oxide synthase prevents LPS-induced acute lung injury in dogs. J Immunol 1998; 160:3031-3037
40. Okamoto I, Abe M, Shibata K, et al: Evaluating the role of inducible nitric oxide synthase using a novel and selective inducible nitric oxide synthase inhibitor in septic lung injury produced by cecal ligation and puncture. Am J Respir Crit Care Med 2000; 162: 716-722
41. Sittipunt C, Steinberg KP, Ruzinski JT, et al: Nitric oxide and nitrotyrosine in the lungs of patients with acute respiratory distress syndrome. Am J Respir Crit Care Med 2001; 163:503-510
42. Ochoa JB, Udekwu AO, Billiar TR, et al: Nitrogen oxide levels in patients after trauma and during sepsis. Ann Surg 1991; 214: 621-626
43. Seth P, Kumari R, Dikshit M, et al: Modulation of rat peripheral polymorphonuclear leukocyte response by nitric oxide and arginine. Blood 1994; 84:2741-2748
44. Terada LS, Mahr NN, Jacobson ED: Nitric oxide decreases lung injury after intestinal ischemia. J Appl Physiol 1996; 81:2456-2460
45. Zingarelii B, Day BJ, Crapo JD, et al: The potential role of peroxynitrite in the vascular contractile and cellular energetic failure in endotoxic shock. Br J Pharmacol 1997; 120: 259-267
46. Robbins CG, Davis JM, Merritt TA, et al: Combined effects of nitric oxide and hyperoxia on surfactant function and pulmonary inflammation. Am J Physiol 1995; 269: L545-L550
47. Annane D, Sanquer S, Sebille V, et al: Compartmentalised inducible nitric-oxide synthase activity in septic shock. Lancet 2000; 355:1143-1148
48. Tomobuchi M, Oshitani N, Matsumoto T, et al: In situ generation of nitric oxide by myenteric neurons but not by mononuclear cells of the human colon. Clin Exp Pharmacol Physiol 2001; 28:13-18
49. Dahm PL, Blomquist S, De Robertis E, et al: Effects of NO inhalation on pulmonary leukocyte sequestration and blood volume in porcine endotoxaemia. Intensive Care Med 2000; 26:336-343
50. Honda K, Kobayashi H, Hataishi R, et al: Inhaled nitric oxide reduces tyrosine nitration after lipopolysaccharide instillation into lungs of rats. Am J Respir Crit Care Med 1999; 160:678-688
51. Basu S: Isoprostanes: Novel bioactive products of lipid peroxidation. Free Radic Res 2004; 38:105-122
52. Pratico D, Rokach J, Lawson J, et al: F2-isoprostanes as indices of lipid peroxidation in inflammatory diseases. Chem Phys Lipids 2004; 128:165-171
53. Morrow JD, Roberts LJ: The isoprostanes: Unique bioactive products of lipid peroxidation. Prog Lipid Res 1997; 36:1-21
54. Ischiropoulos H, Zhu L, Beckman JS: Peroxynitrite formation from macrophage-derived nitric oxide. Arch Biochem Biophys 1992; 298:446-451
55. Pryor WA, Squadrito GL: The chemistry of peroxynitrite: A product from the reaction of nitric oxide with superoxide. Am J Physiol 1995; 268:L699-L722
56. Saleh D, Barnes PJ, Giaid A: Increased production of the potent oxidant peroxynitrite in the lungs of patients with idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 1997; 155:1763-1769
57. Gagnon C, Leblond FA, Filep JG: Peroxynitrite production by human neutrophils, monocytes and lymphocytes chaiienged with lipopolysaccharide. FEBS Lett 1998; 431: 107-110
58. Wizemann TM, Gardner CR, Laskin JD, et al: Production of nitric oxide and peroxynitrite in the lung during acute endotoxemia. J Leukoc Biol 1994; 56:759-768
59. Liaudet L, Pacher P, Mabley JG, et al: Activation of poly(ADP-Ribose) polymerase-1 is a central mechanism of lipopolysaccharide-induced acute lung inflammation. Am J Respir Crit Care Med 2002; 165:372-377
60. Szabo C: Potential role of the peroxynitrite-poly(adp-ribose) synthetase pathway in a rat model of severe hemorrhagic shock. Shock 1998; 9:341-344
61. Eiserich JP, Estevez AG, Bamberg TV, et al: Microtubule dysfunction by posttranslational nitrotyrosination of alpha-tubulin: A nitric oxide-dependent mechanism of cellular injury. Proc Nat Acad Sci USA 1999; 96: 6365-6370
62. Elliott SJ: Peroxynitrite modulates receptor-activated Ca2+ signaling in vascular endothelial cells. Am J Physiol Lung Cell Mol Physiol 1996; 270:L954-L961
63. Szabo C: Role of poly(ADP-ribose)synthetase in inflammation. Eur J Pharmacol 1998; 350:1-19
64. Baldus S, Eiserich JP, Mani A et al: Endothelial transcytosis of myeloperoxidase confers specificity to vascular ECM proteins as targets of tyrosine nitration. J Clin Invest 2001; 108:1759-1770
65. Wu JM, Yeh TF, Wang JY, et al: The role of pulmonary inflammation in the development of pulmonary hypertension in newborn with meconium aspiration syndrome (MAS). Pediatr Pulm 1999; 18-208
66. Radi R: Nitric oxide, oxidants, and protein tyrosine nitration. Proc Natl Acad Sci USA 2004; 101:4003-4008
67. Delateur T, Richoz J, Vuichoud J, et al: Artifactual nitration controlled measurement of protein-bound 3-nitro-L-tyrosine in biological fluids and tissues by isotope dilution liquid chromatography electrospray ionization tandem mass spectrometry. Chem Res Toxicol 2002; 15:1209-1217
68. Yi D, Ingelse BA, Duncan MW, et al: Quantification of 3-nitrotyrosine in biological tissues and fluids: Generating valid results by eliminating artifactual formation. J Am Soc Mass Spectrom 2000; 11:578-586
69. Rixen D, Siegel JH, Espina N, et al: Plasma nitric oxide in posttrauma critical illness: A function of "sepsis" and the physiologic state severity classification quantifying the probability of death. Shock 1997; 7:17-28
70. Krafte-Jacobs B, Brilli R, Szabo C, et al: Circulating methemoglobin and nitrite/nitrate concentrations as indicators of nitric oxide overproduction in critically ill children with septic shock. Crit Care Med 1997; 25: 1588-1593
71. Vincent JL, Zhang H, Szabo C, et al: Effects of nitric oxide in septic shock. Am J Respir Crit Care Med 2000; 161:1781-1785
72. Nava E, Palmer RM, Moncada S: Inhibition of nitric oxide synthesis in septic shock: How much is beneficial? Lancet 1991; 338: 1555-1557
73. Avontuur JA, Nolthenius RP, Vanbodegom JW, et al: Prolonged inhibition of nitric oxide synthesis in severe septic shock - A clinical study. Crit Care Med 1998; 26:660-667
74. Bigatello LM: Nitric oxide: Modulation of the pulmonary circulation. Minerva Anestesiol 2000; 66:307-313